Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Ekaterina S. Kotova, Olga A. Gavrilina, MDPhD, Igor A Yakutik, PhD, Andrey B. Sudarikov, PhD DSc, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Galina A. Isinova, MD PhD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141804

Published: 2020

Journal Articles

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Kseniia I. Zarubina, Elena N. Parovichnikova, MD PhD, Vadim L. Surin, Olesya S. Pshenichnikova, PhD, Ekaterina Y. Demidova, PhD, Bella V. Biderman, PhD, Andrey B. Sudarikov, PhD DSc, Galina A. Baskhaeva, MD PhD, Olga A. Gavrilina, MDPhD, Ekaterina S. Kotova, Andrey N. Sokolov, MD PhD, Vera V. Troitskaya, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-136041

Published: 2020

Journal Articles

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina V. Kokhno, MD PhD, Zalina T. Fidarova, MD PhD, Olga A. Gavrilina, MD PhD, Tatiana I. Lobanova, MD, Elena O. Gribanova, MD PhD, Sergey K. Kravchenko, MD PhD, Gennadiy M. Galstyan, MD PhD, Sergei M. Kulikov, PhD, Julia A. Chabaeva, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5136.

https://doi.org/10.1182/blood-2019-124056

Published: 2019

Journal Articles

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Vera V. Troitskaya, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD PhD, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5183.

https://doi.org/10.1182/blood-2019-128650

Published: 2019

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Elena Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Tatiana I. Lobanova, MD, Yuliya O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD, Alina V. Kokhno, MD, PhD, Roman V. Tivikov, MD, Irina A. Lukyanova, MD, Tatiana N. Obukhova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2018-99-116581

Published: 2018

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blood (2017) 130 (Supplement 1): 2604.

https://doi.org/10.1182/blood.V130.Suppl_1.2604.2604

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Andrey N. Sokolov, MD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, Sergei M. Kulikov, PhD, Sergey N. Bondarenko, PhDMD, Julia O. Davidova, Nikolay M. Kapranov, Irina A. Lukyanova, MD, Tatiana I. Lobanova, MD, Ekaterina I. Usikova, MD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3884.

https://doi.org/10.1182/blood.V130.Suppl_1.3884.3884

Published: 2017

Journal Articles

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Anna A. Sidorova, MD, Gennadii M. Galstian, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Anton Olenev, Olga Korobitsyna, Alexandr Korobkin, MD, Elena Kirillova, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 4665.

https://doi.org/10.1182/blood.V130.Suppl_1.4665.4665

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Andrey N. Sokolov, MD PhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davidova, Nikolai M. Kapranov, Tatiana N. Obukhova, PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 4024.

https://doi.org/10.1182/blood.V128.22.4024.4024

Published: 2016

Journal Articles

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Galina Baskhaeva, MD, Kseniia Zarubina, MD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2805.

https://doi.org/10.1182/blood.V128.22.2805.2805

Published: 2016

Journal Articles

Pregnancy Is a Poor Prognostic Factor for AML Outcome

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, Anna A. Sidorova, MD, Olga A. Gavrilina, MD PhD, Gennadii M. Galstian, MD PhD, Aleksei Bazhenov, MD, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5171.

https://doi.org/10.1182/blood.V128.22.5171.5171

Published: 2016

Journal Articles

No Differences in the Treatment Outcome in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Regarding the Initial Bone Marrow Blasts Count: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey Bondarenko, MD PhD, Olga Baranova, Zalina Akhmerzaeva, Mikhail Rusinov, Sergei M Kulikov, PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5149.

https://doi.org/10.1182/blood.V128.22.5149.5149

Published: 2016

Journal Articles

Late Clonal Disorders in Patients with Aplastic Anemia

Alina Kokhno, MD, PhD, Elena A Mikhaylova, MD PhD Prof, Zalina T. Fidarova, Elena Ustinova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa P. Mendeleeva, MD PhD, Larisa A. Kuzmina, MD PhD, Nina V. Tsvetaeva, MD PhD, Valentina N. Dvirnyk, MD, PhD, Tatiana N. Obukhova, PhD, Alla M. Kovrigina, MD PhD Prof., Elena N. Parovichnikova, MD PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 4787.

https://doi.org/10.1182/blood.V126.23.4787.4787

Published: 2015

Journal Articles

Plasmapheresis Is an Effective Approach Preventing Clinically Significant Tumor Lysis Syndrome during Induction Therapy in AML Patients with Hyperleukocytosis

Vera V Troitskaya, MD, Elena N. Parovichnikova, MD PhD, Andrey N Sokolov, MD, Alina V Kochno, MD, Darima S Badmazhapova, Larisa A Kuzmina, MD, Tatyana V Gaponova, MD, Sergey K. Kravchenko, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5268.

https://doi.org/10.1182/blood.V124.21.5268.5268

Published: 2014

Journal Articles

Non-Intensive but Constant and Exhausting Action on the Leukemic Clone Is a Reasonable and Effective Treatment Approach in Adult Acute Lymphoblastic Leukemia: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Blood (2014) 124 (21): 3662.

https://doi.org/10.1182/blood.V124.21.3662.3662

Published: 2014

Journal Articles

Conventional 7+3 Consolidation Is Equal in Long-Term Outcome to High Dose ARA-C in Case of the High Total Doses of Different Anthracyclines/Anthracenedione in Induction/Consolidation - the Interim Results of Russian Randomized Multicenter AML-10 Trial

Blood (2014) 124 (21): 3667.

https://doi.org/10.1182/blood.V124.21.3667.3667

Published: 2014

NARROW

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Pregnancy Is a Poor Prognostic Factor for AML Outcome

No Differences in the Treatment Outcome in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Regarding the Initial Bone Marrow Blasts Count: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Late Clonal Disorders in Patients with Aplastic Anemia

Plasmapheresis Is an Effective Approach Preventing Clinically Significant Tumor Lysis Syndrome during Induction Therapy in AML Patients with Hyperleukocytosis

Non-Intensive but Constant and Exhausting Action on the Leukemic Clone Is a Reasonable and Effective Treatment Approach in Adult Acute Lymphoblastic Leukemia: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Conventional 7+3 Consolidation Is Equal in Long-Term Outcome to High Dose ARA-C in Case of the High Total Doses of Different Anthracyclines/Anthracenedione in Induction/Consolidation - the Interim Results of Russian Randomized Multicenter AML-10 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only